Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Long-Term Debt Repayments (2024 - 2025)

Bioregenx (BRGX) has 2 years of Long-Term Debt Repayments data on record, last reported at $46674.0 in Q3 2025.

  • For Q3 2025, Long-Term Debt Repayments rose 352.62% year-over-year to $46674.0; the TTM value through Sep 2025 reached $78736.0, up 97.98%, while the annual FY2024 figure was $48240.0, 133.37% up from the prior year.
  • Long-Term Debt Repayments reached $46674.0 in Q3 2025 per BRGX's latest filing, up from $13177.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $46674.0 in Q3 2025 and bottomed at $8470.0 in Q4 2024.